Anne Moore | NIBRT PI
University Colleague Cork

Professor Anne Moore holds a joint position between the School of Biochemistry and Cell Biology, UCC and the National Institute of Bioprocessing Research and Training (NIBRT). She brings to this joint appointment a wealth of expertise in immunology, bioprocessing, and vaccine development. Professor Moore completed a PhD in HIV vaccine immunology with Professor Kingston Mills and subsequently embarked upon postdoctoral work on defects in immune responses in HIV-infected individuals in the Wistar Institute in Philadelphia and further work on recombinant vaccines against viruses such as HIV and Ebola virus in Dr. Gary Nabel's lab, then at the University of Michigan. As a senior immunologist in Prof. Adrian Hill's group in the University of Oxford, she developed several T cell inducing vaccine candidates against malaria, TB and influenza virus. Professor Moore has more recently focussed on developing new stable, injection-free and easy-to-administer delivery technologies to improve global equitable access to vaccines.  In her new role, Professor Moore will lead collaborative research initiatives between NIBRT and UCC, focusing on sustainable, regionalised bioprocessing technologies for vaccine production and deployment.  Leveraging state-of-the-art facilities and multidisciplinary expertise in pre-clinical immunology, biopharmaceutics and bioprocessing across the two institutions, Professor Moore's research will aim to determine how new delivery technologies improve vaccine efficacy, thereby providing better protection against disease and can be integrated into new, sustainable vaccine manufacturing systems, thereby providing improved access to vaccines.